CareDx [CDNA] vs Thermo Fisher [TMO] Detailed Stock Comparison
CareDx
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CareDx wins in 10 metrics, Thermo Fisher wins in 8 metrics, with 0 ties. CareDx appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CareDx | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.91 | 28.17 | CareDx |
| Price-to-Book Ratio | 2.03 | 3.64 | CareDx |
| Debt-to-Equity Ratio | 8.90 | 69.62 | CareDx |
| PEG Ratio | 0.03 | 4.96 | CareDx |
| EV/EBITDA | -17.86 | 19.69 | CareDx |
| Profit Margin (TTM) | 17.06% | 15.24% | CareDx |
| Operating Margin (TTM) | -12.43% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | N/A | 17.84% | N/A |
| Return on Equity | 19.64% | 13.42% | CareDx |
| Return on Assets (TTM) | -5.85% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $31.56M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | -58.91% | -17.51% | Thermo Fisher |
| Price-to-Sales Ratio (TTM) | 1.95 | 4.26 | CareDx |
| Enterprise Value | $508.74M | $213.03B | Thermo Fisher |
| EV/Revenue Ratio | 1.49 | 4.93 | CareDx |
| Gross Profit Margin (TTM) | 66.94% | 40.61% | CareDx |
| Revenue per Share (TTM) | $6 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $1.05 | $17.31 | Thermo Fisher |
| Beta (Stock Volatility) | 2.22 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CareDx vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CareDx | 3.68% | 9.54% | -0.38% | -24.20% | -39.31% | -39.73% |
| Thermo Fisher | 3.36% | 2.25% | 16.93% | 24.85% | -6.64% | -4.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CareDx | -58.91% | -37.90% | -61.89% | 88.92% | 29.60% | 29.60% |
| Thermo Fisher | -17.51% | -11.30% | 17.79% | 295.19% | 1,057.92% | 1,679.96% |
Performance & Financial Health Analysis: CareDx vs Thermo Fisher
| Metric | CDNA | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $665.87M | $184.10B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,294,280 | 2,020,610 |
| 90 Day Avg. Volume | 2,042,987 | 2,900,827 |
| Last Close | $12.97 | $500.00 |
| 52 Week Range | $10.96 - $33.21 | $385.46 - $627.88 |
| % from 52W High | -60.95% | -20.37% |
| All-Time High | $99.83 (Jan 18, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -87.01% | -25.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.03% |
| Quarterly Earnings Growth | -0.06% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.15% |
| Operating Margin (TTM) | -0.12% | 0.18% |
| Return on Equity (TTM) | 0.20% | 0.13% |
| Debt to Equity (MRQ) | 8.90 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.15 | $133.77 |
| Cash per Share (MRQ) | $3.50 | $16.92 |
| Operating Cash Flow (TTM) | $17.72M | $7.58B |
| Levered Free Cash Flow (TTM) | $24.13M | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: CareDx vs Thermo Fisher
| Metric | CDNA | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.91 | 28.17 |
| Forward P/E | 21.57 | 20.76 |
| PEG Ratio | 0.03 | 4.96 |
| Price to Sales (TTM) | 1.95 | 4.26 |
| Price to Book (MRQ) | 2.03 | 3.64 |
| Market Capitalization | ||
| Market Capitalization | $665.87M | $184.10B |
| Enterprise Value | $508.74M | $213.03B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.49 | 4.93 |
| Enterprise to EBITDA | -17.86 | 19.69 |
| Risk & Other Metrics | ||
| Beta | 2.22 | 0.75 |
| Book Value per Share (MRQ) | $6.15 | $133.77 |
Financial Statements Comparison: CareDx vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CDNA | TMO |
|---|---|---|
| Revenue/Sales | $84.69M | $10.36B |
| Cost of Goods Sold | $28.42M | $6.13B |
| Gross Profit | $56.27M | $4.24B |
| Research & Development | $18.52M | $342.00M |
| Operating Income (EBIT) | $-8.01M | $1.82B |
| EBITDA | $2.29M | $2.73B |
| Pre-Tax Income | $-10.30M | $1.62B |
| Income Tax | $58,000 | $95.00M |
| Net Income (Profit) | $-10.35M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CDNA | TMO |
|---|---|---|
| Cash & Equivalents | $88.75M | $4.13B |
| Total Current Assets | $350.24M | $23.38B |
| Total Current Liabilities | $85.28M | $13.17B |
| Long-Term Debt | $24.07M | $31.37B |
| Total Shareholders Equity | $379.35M | $49.49B |
| Retained Earnings | $-636.60M | $54.45B |
| Property, Plant & Equipment | $59.12M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CDNA | TMO |
|---|---|---|
| Operating Cash Flow | $-6.86M | $2.15B |
| Capital Expenditures | N/A | $-350.00M |
| Free Cash Flow | $-28.21M | $361.00M |
| Debt Repayment | N/A | $-838.00M |
| Common Stock Repurchase | $0 | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | CDNA | TMO |
|---|---|---|
| Shares Short | 6.18M | 3.71M |
| Short Ratio | 3.04 | 1.14 |
| Short % of Float | 0.12% | 0.01% |
| Average Daily Volume (10 Day) | 1,294,280 | 2,020,610 |
| Average Daily Volume (90 Day) | 2,042,987 | 2,900,827 |
| Shares Outstanding | 54.77M | 380.77M |
| Float Shares | 51.88M | 376.76M |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 1.02% | 0.92% |
Dividend Analysis & Yield Comparison: CareDx vs Thermo Fisher
| Metric | CDNA | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |